TREATMENT WITH TEDUGLUTIDE IN PATIENTS WITH SHORT BOWEL SYNDROME: PARENTERAL SUPPORT AND BIOELECTRICAL IMPEDANCE ANALYSIS IN CLINICAL ROUTINE
Pevny, S.; Maasberg, S.; Knappe-Drzikova, B.; Thurmann, D.; Pascher, A.; Pape, U. · Aktuelle Ernährungsmedizin · 2017 · Heft 3 · S. 1 bis 1
Bibliografische Angaben
Zusammenfassung
Introduction: Teduglutide (TED), an analogue of glucagon like peptide-2 (GLP-2), a protrophic gastrointestinal hormone that promotes regeneration of the intestinal mucosa, is effective for enhancing intestinal adaption in patients with short bowel syndrome (SBS) and chronic intestinal failure. Thus, it is expected to improve nutritional status, oral autonomy and clinical outcome. Objectives: A retrospective data analysis was performed to describe effects of TED on parenteral infusion requirements and body composition in clinical routine. Methods: Center based clinical and paraclinical data of patients with benig…
